These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37916797)

  • 1. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
    Rijken A; Pape M; Simkens GA; de Hingh IHJT; Luyer MDP; van Sandick JW; van Laarhoven HWM; Verhoeven RHA; van Erning FN
    Int J Cancer; 2024 Mar; 154(6):992-1002. PubMed ID: 37916797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.
    Veld JV; Wisselink DD; Amelung FJ; Consten ECJ; de Wilt JHW; de Hingh I; Bemelman WA; van Hooft JE; Tanis PJ;
    Ann Surg Oncol; 2020 Aug; 27(8):2762-2773. PubMed ID: 32170481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort.
    Koemans WJ; Lurvink RJ; Grootscholten C; Verhoeven RHA; de Hingh IH; van Sandick JW
    Gastric Cancer; 2021 Jul; 24(4):800-809. PubMed ID: 33495964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
    Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
    Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
    Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database.
    Rijken A; Bakkers C; Klümpen HJ; van der Geest LG; de Vos-Geelen J; van Erning FN; de Hingh IHJT
    Eur J Surg Oncol; 2023 Aug; 49(8):1436-1443. PubMed ID: 36898900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based Study.
    Guchelaar NAD; Noordman BJ; Welten MW; van Santen MT; de Neijs MJ; Koolen SLW; Verhoeven RHA; Oomen-de Hoop E; van der Sluis PC; Lagarde SM; van Laarhoven HWM; de Hingh IHJT; Creemers GJ; Mostert B; Wijnhoven BPL; Mathijssen RHJ
    J Natl Compr Canc Netw; 2024 Jul; 22(6):405-412. PubMed ID: 39074509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study.
    Lurvink RJ; Rijken A; Bakkers C; Aarts MJ; Kunst PWA; van de Borne BE; van Erning FN; de Hingh IHJT
    Clin Exp Metastasis; 2021 Jun; 38(3):295-303. PubMed ID: 33738641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer: Update of a Nationwide Cohort.
    Rijken A; Bakkers C; van Erning FN; van der Geest LG; de Vos-Geelen J; Besselink MG; Lemmens VE; de Hingh IHJT;
    Pancreas; 2021 Jul; 50(6):827-833. PubMed ID: 34347730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence.
    Le VH; Thornblade L; Ituarte PHG; Lai LL; Melstrom KA
    J Surg Oncol; 2021 Feb; 123(2):622-629. PubMed ID: 33616972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer.
    Kunitomo A; Ouchi A; Komori K; Kinoshita T; Sato Y; Abe T; Ito S; Sano T; Shimizu Y
    Ann Surg Oncol; 2023 Dec; 30(13):8501-8508. PubMed ID: 37658266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
    Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
    Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study.
    Bastiaenen VP; Aalbers AGJ; Arjona-Sánchez A; Bellato V; van der Bilt JDW; D'Hoore AD; Espinosa-Redondo E; Klaver CEL; Nagtegaal ID; van Ramshorst B; van Santvoort HC; Sica GS; Snaebjornsson P; Wasmann KATGM; de Wilt JHW; Wolthuis AM; Tanis PJ
    Eur J Surg Oncol; 2021 Sep; 47(9):2405-2413. PubMed ID: 34030920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undifferentiated histology after endoscopic resection may predict synchronous and metachronous occurrence of early gastric cancer.
    Seo JH; Park JC; Kim YJ; Shin SK; Lee YC; Lee SK
    Digestion; 2010; 81(1):35-42. PubMed ID: 20029207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma.
    Dietz MV; van Kooten JP; Said I; Brandt-Kerkhof ARM; Verhoef C; Bremers AJA; de Wilt JHW; de Reuver PR; Madsen EVE
    Ann Surg Oncol; 2022 Oct; 29(11):6566-6576. PubMed ID: 35513588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer.
    Reboux N; Jooste V; Goungounga J; Robaszkiewicz M; Nousbaum JB; Bouvier AM
    JAMA Netw Open; 2022 Oct; 5(10):e2236666. PubMed ID: 36239935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
    Madani A; Thomassen I; van Gestel YRBM; van der Bilt JDW; Haak HR; de Hingh IHJT; Lemmens VEPP
    Ann Surg Oncol; 2017 Aug; 24(8):2199-2205. PubMed ID: 28204963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Incidence of Synchronous or Metachronous Tumors after Endoscopic Submucosal Dissection for Early Gastric Cancer with Undifferentiated Histology.
    Park CH; Kim EH; Kang JH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
    PLoS One; 2016; 11(1):e0147874. PubMed ID: 26809013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
    Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
    Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.